Drug
Dilmapimod clinical trials
Also written SB-681323.
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
9 studies that test it; most in 2005 (5)
| Year | Studies |
|---|---|
| 2005 | 5 |
| 2006 | 3 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses dilmapimod is read from its arms, and is right about nine times in ten.
Testing it · 9
- SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDSCompletedPhase 2GlaxoSmithKlineNCT00996840Written as SB-681323 Intravenous 3mg
- P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic PainCompletedPhase 2GlaxoSmithKlineNCT00390845Written as SB681323
- A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid ArthritisCompletedPhase 2GlaxoSmithKlineNCT00134693Written as SB-681323
- SB-681323 In Subjects With Rheumatoid ArthritisCompletedPhase 2GlaxoSmithKlineNCT00320450Written as SB-681323
- A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single DoseCompletedPhase 1GlaxoSmithKlineNCT00439881Written as SB-681323
- Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2GlaxoSmithKlineNCT00144859Written as SB681323
- A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous InterventionCompletedPhase 2GlaxoSmithKlineNCT00291902Written as SB-681323
- SB-681323-Methotrexate Interaction StudyCompletedPhase 1GlaxoSmithKlineNCT00419809Written as SB-681323 oral tablets
- Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) PatientsCompletedPhase 1GlaxoSmithKlineNCT00380133Written as SB681323
Codes
What other systems call dilmapimod · ClinicalTrials.gg INT006120
- MeSH (NLM) C574213dilmapimodConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) Q3238VQW0NDILMAPIMODConfirmed FDA, NLM, Wikidata
- Wikidata Q27077064dilmapimodConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C96531DilmapimodOne source FDA
- DrugBank DB12140One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C574213 | dilmapimod | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | Q3238VQW0N | DILMAPIMOD | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27077064 | dilmapimod | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C96531 | Dilmapimod | One source FDA |
| DrugBank | DB12140 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.